|
1
|
Ivan IM, Olaru OT, Popovici V, Chițescu CL, Popescu L, Luță EA, Ilie EI, Brașoveanu LI, Hotnog CM, Nițulescu GM, Boscencu R, Gîrd CE. Antioxidant and Cytotoxic Properties of Berberis vulgaris (L.) Stem Bark Dry Extract. Molecules 2024; 29:2053. [PMID: 38731544 PMCID: PMC11085362 DOI: 10.3390/molecules29092053] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2024] [Revised: 04/26/2024] [Accepted: 04/27/2024] [Indexed: 05/13/2024] Open
Abstract
Berberis vulgaris (L.) has remarkable ethnopharmacological properties and is widely used in traditional medicine. The present study investigated B. vulgaris stem bark (Berberidis cortex) by extraction with 50% ethanol. The main secondary metabolites were quantified, resulting in a polyphenols content of 17.6780 ± 3.9320 mg Eq tannic acid/100 g extract, phenolic acids amount of 3.3886 ± 0.3481 mg Eq chlorogenic acid/100 g extract and 78.95 µg/g berberine. The dried hydro-ethanolic extract (BVE) was thoroughly analyzed using Ultra-High-Performance Liquid Chromatography coupled with High-Resolution Mass Spectrometry (UHPLC-HRMS/MS) and HPLC, and 40 bioactive phenolic constituents were identified. Then, the antioxidant potential of BVE was evaluated using three methods. Our results could explain the protective effects of Berberidis cortex EC50FRAP = 0.1398 mg/mL, IC50ABTS = 0.0442 mg/mL, IC50DPPH = 0.2610 mg/mL compared to ascorbic acid (IC50 = 0.0165 mg/mL). Next, the acute toxicity and teratogenicity of BVE and berberine-berberine sulfate hydrate (BS)-investigated on Daphnia sp. revealed significant BS toxicity after 24 h, while BVE revealed considerable toxicity after 48 h and induced embryonic developmental delays. Finally, the anticancer effects of BVE and BS were evaluated in different tumor cell lines after 24 and 48 h of treatments. The MTS assay evidenced dose- and time-dependent antiproliferative activity, which was higher for BS than BVE. The strongest diminution of tumor cell viability was recorded in the breast (MDA-MB-231), colon (LoVo) cancer, and OSCC (PE/CA-PJ49) cell lines after 48 h of exposure (IC50 < 100 µg/mL). However, no cytotoxicity was reported in the normal epithelial cells (HUVEC) and hepatocellular carcinoma (HT-29) cell lines. Extensive data analysis supports our results, showing a significant correlation between the BVE concentration, phenolic compounds content, antioxidant activity, exposure time, and the viability rate of various normal cells and cancer cell lines.
Collapse
Affiliation(s)
- Ionuț Mădălin Ivan
- Faculty of Pharmacy, University of Medicine and Pharmacy “Carol Davila”, Traian Vuia 6, 020956 Bucharest, Romania; (I.M.I.); (L.P.); (E.A.L.); (E.I.I.); (G.M.N.); (R.B.); (C.E.G.)
| | - Octavian Tudorel Olaru
- Faculty of Pharmacy, University of Medicine and Pharmacy “Carol Davila”, Traian Vuia 6, 020956 Bucharest, Romania; (I.M.I.); (L.P.); (E.A.L.); (E.I.I.); (G.M.N.); (R.B.); (C.E.G.)
| | - Violeta Popovici
- Center for Mountain Economics, “Costin C. Kiriţescu” National Institute of Economic Research (INCE-CEMONT), Romanian Academy, 725700 Vatra-Dornei, Romania
| | - Carmen Lidia Chițescu
- Faculty of Medicine and Pharmacy, “Dunărea de Jos” University of Galați, A.I. Cuza 35, 800010 Galați, Romania;
| | - Liliana Popescu
- Faculty of Pharmacy, University of Medicine and Pharmacy “Carol Davila”, Traian Vuia 6, 020956 Bucharest, Romania; (I.M.I.); (L.P.); (E.A.L.); (E.I.I.); (G.M.N.); (R.B.); (C.E.G.)
| | - Emanuela Alice Luță
- Faculty of Pharmacy, University of Medicine and Pharmacy “Carol Davila”, Traian Vuia 6, 020956 Bucharest, Romania; (I.M.I.); (L.P.); (E.A.L.); (E.I.I.); (G.M.N.); (R.B.); (C.E.G.)
| | - Elena Iuliana Ilie
- Faculty of Pharmacy, University of Medicine and Pharmacy “Carol Davila”, Traian Vuia 6, 020956 Bucharest, Romania; (I.M.I.); (L.P.); (E.A.L.); (E.I.I.); (G.M.N.); (R.B.); (C.E.G.)
| | - Lorelei Irina Brașoveanu
- Center of Immunology, “Stefan S. Nicolau” Institute of Virology, Romanian Academy, 285 Mihai Bravu Ave., 030304 Bucharest, Romania; (L.I.B.); (C.M.H.)
| | - Camelia Mia Hotnog
- Center of Immunology, “Stefan S. Nicolau” Institute of Virology, Romanian Academy, 285 Mihai Bravu Ave., 030304 Bucharest, Romania; (L.I.B.); (C.M.H.)
| | - George Mihai Nițulescu
- Faculty of Pharmacy, University of Medicine and Pharmacy “Carol Davila”, Traian Vuia 6, 020956 Bucharest, Romania; (I.M.I.); (L.P.); (E.A.L.); (E.I.I.); (G.M.N.); (R.B.); (C.E.G.)
| | - Rica Boscencu
- Faculty of Pharmacy, University of Medicine and Pharmacy “Carol Davila”, Traian Vuia 6, 020956 Bucharest, Romania; (I.M.I.); (L.P.); (E.A.L.); (E.I.I.); (G.M.N.); (R.B.); (C.E.G.)
| | - Cerasela Elena Gîrd
- Faculty of Pharmacy, University of Medicine and Pharmacy “Carol Davila”, Traian Vuia 6, 020956 Bucharest, Romania; (I.M.I.); (L.P.); (E.A.L.); (E.I.I.); (G.M.N.); (R.B.); (C.E.G.)
| |
Collapse
|